Questions & Correct Answers with Detailed Rationales | Complete
Exam-Style Questions | Graded A+ Pass Guaranteed
SECTION I: Neurobiology and Neuroanatomy
Question 1
Which neurotransmitter pathway, originating in the ventral tegmental area and
projecting to the nucleus accumbens, prefrontal cortex, and limbic structures, is
primarily implicated in the reward circuitry dysfunction observed in schizophrenia and is
the principal target of most antipsychotic medications?
A. Serotonergic pathway from the raphe nuclei
B. Dopaminergic mesolimbic and mesocortical pathways
C. Noradrenergic pathway from the locus coeruleus
D. Cholinergic pathway from the nucleus basalis of Meynert
Correct Answer: B
Rationale: Option B is correct because the mesolimbic and mesocortical dopamine
pathways are central to the positive and negative symptoms of schizophrenia.
Hyperactivity in the mesolimbic pathway is associated with positive symptoms
(hallucinations, delusions), while hypofunction in the mesocortical pathway relates to
negative symptoms (avolition, flat affect). Most antipsychotics exert therapeutic effects
primarily through dopamine D2 receptor antagonism in these pathways. Option A is
incorrect because serotonergic pathways are more implicated in mood regulation and
are secondary targets for atypical antipsychotics. Option C is incorrect because
noradrenergic pathways are primarily involved in arousal, attention, and stress
response. Option D is incorrect because cholinergic pathways are more associated with
,memory and cognitive function, and their disruption is linked to dementia rather than
schizophrenia.
Question 2
A 28-year-old patient with treatment-resistant depression is being considered for
transcranial magnetic stimulation (TMS). The PMHNP explains that TMS targets which
specific cortical region to modulate neuronal activity and improve depressive
symptoms?
A. The hippocampus
B. The amygdala
C. The dorsolateral prefrontal cortex (DLPFC)
D. The anterior cingulate cortex
Correct Answer: C
Rationale: Option C is correct because repetitive transcranial magnetic stimulation
(rTMS) for depression typically targets the left dorsolateral prefrontal cortex (DLPFC),
which is hypoactive in major depressive disorder. High-frequency stimulation of the left
DLPFC increases cortical excitability and modulates downstream limbic and subcortical
circuits involved in mood regulation. Option A is incorrect because the hippocampus,
while critically involved in memory and stress response, is not the primary target for
standard TMS protocols. Option B is incorrect because the amygdala is a subcortical
structure deeply involved in emotional processing but is not directly accessible with
standard TMS coils. Option D is incorrect because although the anterior cingulate
cortex is involved in emotion regulation and is sometimes targeted in deep TMS
protocols, the DLPFC remains the standard and most evidence-based target for
conventional rTMS.
Question 3
,Which neurotransmitter system is primarily responsible for the anxiolytic effects of
benzodiazepines, and which receptor subtype mediates their sedative and
anticonvulsant properties?
A. GABA-A receptor; alpha-1 subunit
B. GABA-A receptor; alpha-2 subunit
C. GABA-B receptor; alpha-1 subunit
D. GABA-A receptor; beta-2 subunit
Correct Answer: B
Rationale: Option B is correct because benzodiazepines exert their anxiolytic effects
primarily through positive allosteric modulation of GABA-A receptors containing the
alpha-2 subunit. The alpha-2 subunit is predominantly expressed in limbic structures
and is associated with anxiolytic effects, while the alpha-1 subunit (found in Option A) is
more associated with sedative, amnestic, and anticonvulsant properties. Option C is
incorrect because GABA-B receptors are not the primary target of benzodiazepines; they
are targeted by baclofen and other agents. Option D is incorrect because while beta
subunits are essential components of the GABA-A receptor complex, they do not confer
benzodiazepine sensitivity; alpha subunits are the critical determinants of
benzodiazepine pharmacology.
Question 4
A PMHNP is educating a patient about the neurobiological basis of post-traumatic
stress disorder (PTSD). Which brain region, known for its role in fear conditioning and
memory consolidation, demonstrates hyperactivity in PTSD and is modulated by
evidence-based treatments such as prolonged exposure therapy?
A. The prefrontal cortex
B. The hippocampus
C. The amygdala
D. The hypothalamus
, Correct Answer: C
Rationale: Option C is correct because the amygdala is hyperactive in PTSD and is
central to fear conditioning, threat detection, and emotional memory consolidation.
Neuroimaging studies consistently demonstrate amygdala hyperreactivity to
trauma-related stimuli in individuals with PTSD. Evidence-based treatments like
prolonged exposure therapy and cognitive processing therapy aim to extinguish
conditioned fear responses and modulate amygdala reactivity. Option A is incorrect
because the prefrontal cortex, particularly the medial prefrontal cortex, typically shows
hypoactivity and reduced top-down regulation of the amygdala in PTSD. Option B is
incorrect because the hippocampus, while involved in contextual memory and often
showing reduced volume in PTSD, is not the primary region associated with
hyperactivity and fear conditioning. Option D is incorrect because the hypothalamus,
though involved in the HPA axis stress response, is not the central structure for fear
conditioning and memory consolidation.
Question 5
Which second-messenger system is most directly involved in the mechanism of action
of lithium carbonate, contributing to its mood-stabilizing effects in bipolar disorder?
A. Inhibition of phospholipase C and reduction of inositol monophosphatase activity
B. Activation of adenylyl cyclase and increased cyclic AMP production
C. Blockade of NMDA receptors and decreased calcium influx
D. Inhibition of monoamine oxidase and reduced catecholamine metabolism
Correct Answer: A
Rationale: Option A is correct because lithium's primary mechanism of action involves
inhibition of inositol monophosphatase and inositol polyphosphate 1-phosphatase,
leading to depletion of inositol and subsequent reduction in the phosphatidylinositol (PI)
second-messenger system. This affects multiple downstream signaling pathways